MoneyWorks4Me

Jubilant Pharmova informs about disclosure

20 Jul 2024 Evaluate
Jubilant Pharmova has informed that it enclosed a communication pursuant to Provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Company has received communication from USFDA at 01:44 am (IST) on July 19, 2024. The above mentioned document will be simultaneously posted on the Company's website at www.jubilantpharmova.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..